Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (171-180 of 430) with videos related to

Pageof 43
Sort By:
Cancer|June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastasesLance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1985
Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testisC J Logothetis, M L Samuels, D Selig, et al.
The Journal of Urology|September 1, 1994
Phase II trial of low dose gamma-interferon in metastatic renal cell carcinomaJ A Ellerhorst, R G Kilbourn, R J Amato, et al.
Anticancer Research|May 1, 1994
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimenC J Logothetis, E Hossan, G Recondo, et al.
Cancer Biotherapy|January 1, 1995
Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancerA Sella, B B Aggarwal, R G Kilbourn, et al.
The Journal of Urology|June 1, 1988
Adjuvant chemotherapy of bladder cancer: a preliminary reportC J Logothetis, D E Johnson, C Chong, et al.
Urologic Oncology|January 13, 2011
A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignanciesS M Tu, E D Robinson, R J Amato, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cellsVemparala Subbarayan, Anita L Sabichi, Jeri Kim, et al.
The Prostate|June 22, 2010
Adipose tissue-derived stem cells promote prostate tumor growthLukas Prantl, Fabian Muehlberg, Nora M Navone, et al.
Neurology|March 1, 1972
Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspectsJ Logothetis, M Constantoulakis, J Economidou, et al.
Pageof 43

Showing results (171-180 of 430) with videos related to

Sort By:
Pageof 43
Cancer|June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastasesLance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1985
Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testisC J Logothetis, M L Samuels, D Selig, et al.
The Journal of Urology|September 1, 1994
Phase II trial of low dose gamma-interferon in metastatic renal cell carcinomaJ A Ellerhorst, R G Kilbourn, R J Amato, et al.
Anticancer Research|May 1, 1994
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimenC J Logothetis, E Hossan, G Recondo, et al.
Cancer Biotherapy|January 1, 1995
Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancerA Sella, B B Aggarwal, R G Kilbourn, et al.
The Journal of Urology|June 1, 1988
Adjuvant chemotherapy of bladder cancer: a preliminary reportC J Logothetis, D E Johnson, C Chong, et al.
Urologic Oncology|January 13, 2011
A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignanciesS M Tu, E D Robinson, R J Amato, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cellsVemparala Subbarayan, Anita L Sabichi, Jeri Kim, et al.
The Prostate|June 22, 2010
Adipose tissue-derived stem cells promote prostate tumor growthLukas Prantl, Fabian Muehlberg, Nora M Navone, et al.
Neurology|March 1, 1972
Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspectsJ Logothetis, M Constantoulakis, J Economidou, et al.
Pageof 43